Tina Powney

Tina Powney, a resident of Shepparton, Victoria, has been living with idiopathic pulmonary arterial hypertension (IPAH) for 26 years, facing significant daily challenges due to her condition. Her current treatment requires a continuous IV infusion managed by a specialized pump, which complicates her daily life. Powney has expressed her hope for access to the newly approved drug Sotatercept, which could drastically improve her quality of life but remains unavailable under Australia's Pharmaceutical Benefits Scheme.